FBIO | tickerfilter.com

Fundamental analysis

26%

Profitability 0%

Dept financing 25%

Liquidity 75%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.29%

1 Month

-15.52%

3 Months

-29.33%

6 Months

-3.92%

1 Year

-22.63%

2 Year

100.96%

Key data

Stock price

$1.47

P/E Ratio

0.00

DAY RANGE

$1.36 - $1.55

EPS

-$2.71

52 WEEK RANGE

$1.36 - $2.89

52 WEEK CHANGE

-$22.22

MARKET CAP

37.918 M

YIELD

N/A

SHARES OUTSTANDING

22.814 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-14-2025

BETA

1.63

PUBLIC FLOAT

AVERAGE 10 VOLUME

$233,783

AVERAGE 30 VOLUME

$372,379

Company detail

CEO: Lindsay A. Rosenwald
Region: US
Website: fortressbiotech.com
Employees: 170
IPO year: 2011

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also develops late stage product candidates such as intravenous Tramadol for the treatment of post-operative acute pain.

FBIO - Fortress Biotech, Inc.